UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pancreatic Safety of Incretin-Based Drugs — FDA and EMA Assessment

The New England journal of medicine, 2014-02, Vol.370 (9), p.794-797

2014

Volltextzugriff (PDF)

Regulatory aspects of the development of drugs for metabolic bone diseases – FDA and EMA perspective

British journal of clinical pharmacology, 2019-06, Vol.85 (6), p.1208-1212

2019

Volltextzugriff (PDF)

The European Medicines Agency's approval of proprotein convertase subtilisin/kexin type 9 inhibitors

European heart journal, 2021-05, Vol.42 (18), p.e2-e3

2021

Volltextzugriff (PDF)

The European Medicines Agency's approval of new medicines for type 2 diabetes

Diabetes, obesity & metabolism, 2018-09, Vol.20 (9), p.2059-2063

2018

Volltextzugriff (PDF)

Twenty years of progress with parathyroid hormone (PTH): from specialized and "difficult" measurement to common laboratory parameter and treatment option in osteoporosis

Clinical laboratory (Heidelberg), 2008, Vol.54 (11-12), p.439

Blind, Eberhard

2008

Volltextzugriff (PDF)

Effects of Two Years of Daily Teriparatide Treatment on BMD in Postmenopausal Women With Severe Osteoporosis With and Without Prior Antiresorptive Treatment

Journal of bone and mineral research, 2008-10, Vol.23 (10), p.1591-1600

2008

Volltextzugriff (PDF)

Comment on the editorial by Turner et al. on assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion by Zannad et al

European heart journal. Cardiovascular pharmacotherapy, 2017-07, Vol.3 (3), p.129-129

2017

Volltextzugriff (PDF)

CardioPulse: The European Medicines Agency's approval of proprotein convertase subtilisin/kexin type 9 inhibitors

European heart journal, 2016-02, Vol.37 (6), p.502-503

2016

Volltextzugriff (PDF)

The European Medicines Agency's approval of proprotein convertase subtilisin/kexin type 9 inhibitors

European heart journal, 2015-12

2015

Volltextzugriff (PDF)

Preoperative evaluation of microencapsulated human parathyroid tissue aids selection of the optimal bioartificial graft for human parathyroid allotransplantation

Transplant international, 2007-08, Vol.20 (8), p.688-696

2007

Volltextzugriff (PDF)

Agonist-stimulated phosphorylation of the G protein-coupled receptor for parathyroid hormone (PTH) and PTH-related protein

Endocrinology (Philadelphia), 1995-10, Vol.136 (10), p.4271-4277

1995

Volltextzugriff (PDF)

Signaling of the human calcium-sensing receptor expressed in HEK293-cells is modulated by protein kinases A and C

Experimental and clinical endocrinology & diabetes, 2003-02, Vol.111 (1), p.21-26

2003

Volltextzugriff (PDF)

Phosphorylation of the cytoplasmic tail of the PTH/PTHrP receptor

Journal of bone and mineral research, 1996-05, Vol.11 (5), p.578-586

1996

Volltextzugriff (PDF)

Two-site assay of intact parathyroid hormone in the investigation of primary hyperparathyroidism and other disorders of calcium metabolism compared with a midregion assay

The journal of clinical endocrinology and metabolism, 1988-08, Vol.67 (2), p.353-360

1988

Volltextzugriff (PDF)

Serum levels of intact parathyroid hormone and alkaline phosphatase correlate with cortical and trabecular bone loss in primary hyperparathyroidism

Acta endocrinologica (Copenhagen), 1992-10, Vol.127 (4), p.319-323

1992

Volltextzugriff (PDF)

Circulating levels of midregional parathyroid hormone-related protein in hypercalcaemia of malignancy

Clinical endocrinology (Oxford), 1992-09, Vol.37 (3), p.290-297

1992

Volltextzugriff (PDF)

Tumor necrosis factor α inhibits the stimulatory effect of the parathyroid hormone-related protein on cyclic AMP formation in osteoblast-like cells via protein kinase C

Biochemical and biophysical research communications, 1992-01, Vol.182 (1), p.341-347

1992

Volltextzugriff (PDF)

Chromogranin A as Tumor Marker in Medullary Thyroid Carcinoma

Thyroid (New York, N.Y.), 1992, Vol.2 (1), p.5-10

1992

Volltextzugriff (PDF)

Effects of passive immunization against parathyroid hormone‐related protein: PTHrP is the responsible factor in mediating hypercalcemia in the walker carcinosarcoma 256 rat model

Journal of bone and mineral research, 1995-01, Vol.10 (1), p.7-16

1995

Volltextzugriff (PDF)

Development and Validation of an Assay to Measure Bioactivity of Human Calcitonin in Vitro Using T47D Cell Membranes

Analytical biochemistry, 1993-07, Vol.212 (1), p.91-97

1993

Volltextzugriff (PDF)

Adressenverzeichnis

Innere Medizin, 2009, p.VII-XIII

Sixth Edition, 2009

Volltextzugriff (PDF)

Characterization of Antibodies Against Human N-Terminal Parathyroid Hormone by Epitope Mapping

Journal of immunoassay (Monticello, N.Y.), 1992-03, Vol.13 (1), p.1-13

1992

Volltextzugriff (PDF)

Standard essential patents and global ICT value chains with a focus on the catching-up of China

Telecommunications policy, 2022-03, Vol.46 (2), p.102110, Article 102110

2022

Volltextzugriff (PDF)

Fleckerlteppiche und Frühförderung: 20 Jahre Frühförderung mehrfachbehinderter sehbehinderter und blinder Kinder in Bayern. Ergebnisse eines Symposiums vom 30.9. bis 2.10.1997 in der Blindeninstitutsstiftung in Würzburg

Blindeninstitutsstiftung (Würzburg u.a.)

1998

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(17)

Publikationsform

Sprache

Englisch
(24)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(18)
Humans
(17)
Life Sciences & Biomedicine
(17)
Biological And Medical Sciences
(11)
Endocrinology & Metabolism
(8)
Animals
(6)
Female
(6)
Fundamental And Applied Biological Sciences. Psychology
(6)
Medical Sciences
(6)
Cell Line
(5)
Radioimmunoassay
(5)
Rats
(5)
Amino Acid Sequence
(4)
Biochemistry & Molecular Biology
(4)
Male
(4)
Molecular And Cellular Biology
(4)
Parathyroid Hormone - Blood
(4)
Parathyroid Hormone-Related Protein
(4)
Cells, Cultured
(3)
Endocrinopathies
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pancreatic Safety of Incretin-Based Drugs — FDA and EMA Assessment

Regulatory aspects of the development of drugs for metabolic bone diseases – FDA and EMA perspective

The European Medicines Agency's approval of proprotein convertase subtilisin/kexin type 9 inhibitors

The European Medicines Agency's approval of new medicines for type 2 diabetes

Twenty years of progress with parathyroid hormone (PTH): from specialized and "difficult" measurement to common laboratory parameter and treatment option in osteoporosis

Effects of Two Years of Daily Teriparatide Treatment on BMD in Postmenopausal Women With Severe Osteoporosis With and Without Prior Antiresorptive Treatment

Functional characterization of GATA3 mutations causing the hypoparathyroidism-deafness-renal (HDR) dysplasia syndrome: insight into mechanisms of DNA binding by the GATA3 transcription factor

Comment on the editorial by Turner et al. on assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion by Zannad et al

CardioPulse: The European Medicines Agency's approval of proprotein convertase subtilisin/kexin type 9 inhibitors

The European Medicines Agency's approval of proprotein convertase subtilisin/kexin type 9 inhibitors

Preoperative evaluation of microencapsulated human parathyroid tissue aids selection of the optimal bioartificial graft for human parathyroid allotransplantation

Agonist-stimulated phosphorylation of the G protein-coupled receptor for parathyroid hormone (PTH) and PTH-related protein

Signaling of the human calcium-sensing receptor expressed in HEK293-cells is modulated by protein kinases A and C

Phosphorylation of the cytoplasmic tail of the PTH/PTHrP receptor

Two-site assay of intact parathyroid hormone in the investigation of primary hyperparathyroidism and other disorders of calcium metabolism compared with a midregion assay

Serum levels of intact parathyroid hormone and alkaline phosphatase correlate with cortical and trabecular bone loss in primary hyperparathyroidism

Circulating levels of midregional parathyroid hormone-related protein in hypercalcaemia of malignancy

Tumor necrosis factor α inhibits the stimulatory effect of the parathyroid hormone-related protein on cyclic AMP formation in osteoblast-like cells via protein kinase C

Chromogranin A as Tumor Marker in Medullary Thyroid Carcinoma

Effects of passive immunization against parathyroid hormone‐related protein: PTHrP is the responsible factor in mediating hypercalcemia in the walker carcinosarcoma 256 rat model

Development and Validation of an Assay to Measure Bioactivity of Human Calcitonin in Vitro Using T47D Cell Membranes

Adressenverzeichnis

Characterization of Antibodies Against Human N-Terminal Parathyroid Hormone by Epitope Mapping

Standard essential patents and global ICT value chains with a focus on the catching-up of China

Fleckerlteppiche und Frühförderung: 20 Jahre Frühförderung mehrfachbehinderter sehbehinderter und blinder Kinder in Bayern. Ergebnisse eines Symposiums vom 30.9. bis 2.10.1997 in der Blindeninstitutsstiftung in Würzburg

Suchergebnisse filtern